Profiling of differentially expressed apoptosis-related genes by cDNA arrays in human cord blood CD34+ cells treated with etoposide (Q44366709)

2 December 2017

Profiling of differentially expressed apoptosis-related genes by cDNA arrays in human cord blood CD34+ cells treated with etoposide (English)

1 reference

2 December 2017

6

Hal E Broxmeyer

1 reference

2 December 2017

2

Giao Hangoc

1 reference

2 December 2017

Wen Tao

1

1 reference

2 December 2017

John W Hawes

series ordinal

3

1 reference

2 December 2017

Yue Si

series ordinal

4

1 reference

2 December 2017

Scott Cooper

series ordinal

5

1 reference

2 December 2017

1 March 2003

1 reference

2 December 2017

Experimental Hematology

1 reference

2 December 2017

31

1 reference

2 December 2017

3

1 reference

2 December 2017

251-260

1 reference

Diversification of haematopoietic stem cells to specific lineages.

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Stem cells, cancer, and cancer stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Hematopoietic stem-cell transplants using umbilical-cord blood

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

CD34+AC133+ Cells Isolated from Cord Blood are Highly Enriched in Long‐Term Culture‐Initiating Cells, NOD/SCID‐Repopulating Cells and Dendritic Cell Progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Toward regenerative medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

CD34(+) cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Ex vivo expansion of hematopoietic stem and progenitor cells: are we there yet?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Clinical applications of anticancer drugs targeted to topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Etoposide: four decades of development of a topoisomerase II inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Molecular analysis of yeast and human type II topoisomerases. Enzyme-DNA and drug interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Defying death after DNA damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

What does it mean to identify a protein in proteomics?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Apoptosis: a link between cancer genetics and chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Four deaths and a funeral: from caspases to alternative mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

The biochemistry of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

BCL-2 family members and the mitochondria in apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Exploring the metabolic and genetic control of gene expression on a genomic scale

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Differential gene expression profiling of adult murine hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Constitutive tyrosine phosphorylation of the T-cell receptor (TCR) zeta subunit: regulation of TCR-associated protein tyrosine kinase activity by TCR zeta.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

MDM2--master regulator of the p53 tumor suppressor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Regulation of p53 stability and activity in response to genotoxic stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Identification of Myc-mediated death response pathways by microarray analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

c-Myc is necessary for DNA damage-induced apoptosis in the G(2) phase of the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

1 reference

7 January 2021

Disentangling the MYC web.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

CDK2 encodes a 33-kDa cyclin A-associated protein kinase and is expressed before CDC2 in the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Regulation of cyclin-Cdk activity in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Distinct roles for cyclin-dependent kinases in cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Inhibition of Mcm4,6,7 helicase activity by phosphorylation with cyclin A/Cdk2

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Delayed early embryonic lethality following disruption of the murine cyclin A2 gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

From bench to clinic with apoptosis-based therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Targeting death and decoy receptors of the tumour-necrosis factor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Tumor necrosis factor receptor-associated factors (TRAFs)

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2802%2901083-4

7 January 2021

10.1016/S0301-472X(02)01083-4

Identifiers

DOI

1 reference

2 December 2017

1 reference